Home / Publication / A Bottom-up Whole-body Physiologically-based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins

論文

A Bottom-up Whole-body Physiologically-based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins

Author(s): Katherine Gill, Iain Gardner, Linzhong Li, Masoud Jamei

Year: 2016年1月1日

Essentials of Model-informed Drug Development in Oncology

ブログ

Non-Animal Navigator™: 動物実験の削減、改善、代替を実現する戦略とAIを活用したシミュレーション

製品紹介資料

Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions

ウェビナー

Enabling Personalized Therapy with PBPK Modeling for Pediatric Epilepsy

事例紹介

Powered by Translations.com GlobalLink Web Software

A Bottom-up Whole-body Physiologically-based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins

A Bottom-up Whole-body Physiologically-based Pharmacokinetic Model to Mechanistically Predict Tissue Distribution and the Rate of Subcutaneous Absorption of Therapeutic Proteins

Essentials of Model-informed Drug Development in Oncology

Non-Animal Navigator™: 動物実験の削減、改善、代替を実現する戦略とAIを活用したシミュレーション

Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions

Enabling Personalized Therapy with PBPK Modeling for Pediatric Epilepsy

メルマガ登録

クイックアクセス

ソリューション

お問合せ